Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
11
×
boston blog main
11
×
life sciences
national blog main
boston top stories
clinical trials
national top stories
boston
deals
fda
san francisco blog main
new york blog main
san diego blog main
san diego top stories
san francisco top stories
startups
cancer diagnostics
ipo
medical device
national
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
abbvie
amgen
arvinas
bayer
biotech ipos
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
freenome
grail
guardant health
indiana blog main
indiana top stories
investing
What
company
11
×
ipo
developing
drug
medicines
million
new
public
raised
raises
tests
bio
biology
biotech
blood
brings
cancer
close
files
firms
genetic
life
plans
science
synthetic
therapeutics
treatment
way
week
acquire
acquisitions
advance
agreed
aiming
albert
analysis
announced
area
bacteria
based
Language
unset
unknown
Current search:
biotech
×
company
×
" boston blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
4 years ago
Synlogic Lands $80M from Ginkgo to Ramp Up “Living Medicines” R&D
@xconomy.com
5 years ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
5 years ago
Renovia Raises $42M to Back Digital Treatment for Incontinence